MEDEVA SEMPREX-D
Generic Name: acrivastine/pseudoephedrine
Pill imprint MEDEVA SEMPREX-D has been identified as Semprex-D 8 mg-60 mg.
Semprex-D is used in the treatment of nasal congestion; hay fever and belongs to the drug class upper respiratory combinations. There is no proven risk in humans during pregnancy.
Semprex-D 8 mg-60 mg is not subject to the Controlled Substances Act.
See also related documents.
Semprex-D Images
- Generic Name:
- acrivastine/pseudoephedrine
- Imprint:
-
MEDEVA
SEMPREX-D - Strength:
- 8 mg-60 mg
- Color:
- Green & White
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose
magnesium stearate
sodium starch glycolate
gelatin
D&C Yellow No. 10
FD&C Green No. 3
titanium dioxide
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Celltech Pharmaceuticals Inc.
- National Drug Code (NDC):
- 53014-0404
Advertisement
More Semprex-D resources
Search Again
